| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Republic of Korea | 4 | |
| #2 | Mexico | 3 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | Australia | 1 | |
| #5 | Brazil | 1 | |
| #6 | EAPO (Eurasian Patent Organization) | 1 | |
| #7 | Hungary | 1 | |
| #8 | Serbia | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Environmental technology |
| # | Name | Total Patents |
|---|---|---|
| #1 | Hoveyda Hamid | 10 |
| #2 | Fraser Graeme | 9 |
| #3 | Dutheuil Guillaume | 8 |
| #4 | Hamid Hoveyda | 4 |
| #5 | Guillaume Dutheuil | 4 |
| #6 | El Bousmaqui Mohamed | 2 |
| #7 | Graeme Fraser | 2 |
| #8 | Batt Frederic | 2 |
| #9 | Frédéric Batt | 1 |
| #10 | Roy Marie-Odile | 1 |
| Publication | Filing date | Title |
|---|---|---|
| MX2017003980A | Novel chiral synthesis of n-acyl-(3-substituted)-(8-substituted)- 5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines. | |
| KR20190132703A | NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF |